MedWatch

Analyst: Listed subsidiary may pave the way for WSA and take chunk out of massive debt

WS Audiology's subsidiary Hear.com going public could shave down a sizeable chunk of the hearing aid firm's billion kroner debt, according to a CIB analyst. He notes that when the subsidiary goes public this will generate positive attention around WSA which can positively impact the possibility of WSA getting listed.

Photo: WS Audiology / PR

On Tuesday, Danish hearing aid company WS Audiology garnered attention due to its announcement that it would be taking its Dutch-domiciled subsidiary Hear.com public on the US stock exchange.

Carnegie Investment Bank Head of Equity Research and long-time hearing industry analyst Niels Granholm-Leth holds that this decision is rooted in some rational explanations.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs